Background Parvovirus B19 is the causative agent for erythema infectiosum, and also as a
potentially life-threatening infectious agent, it is mainly presented in high erythrocyte …

Abstract Human Parvovirus B19 (B19V) is a recognized cause of life‐threatening conditions
among patients with hemoglobinopathies. This study investigates B19V infection in patients …

Introduction: Parvovirus B19 is a cause of hemolysis and red blood cell aplasia in patients
with sickle cell anemia. The present study aimed to assess parvovirus B19 infection among …

Background Human parvovirus B19 is the etiologic agent of erythema infectiosum in
children. It is also associated with other clinical manifestations in different target groups …

Background Due to the tropism of human parvovirus B19 to erythroid progenitor cells,
infection in patients with an underlying hemolytic disorder such as beta-thalassemia major …

Human parvovirus B19 (B19V) infection can be a life-threatening condition among patients
with hereditary (chronic) hemolytic anemias. Our objective was to characterize the infection …

Background The distribution of human parvovirus B19 (HPV B19) infection is ubiquitous and
occurs worldwide. The virus has high tropism to red blood cells progenitor's cells leading to …

Abstract Introduction: Parvovirus B19 (PVB19) is a DNA virus transmissible by blood
transfusion. It is a major cause of aplastic crisis especially in chronic haemolytic anaemic …

Clinical, biochemical and molecular evidence for the sickle cell anemia (SCA) crisis in
Nigerian patients arising from parvovirus b19 infection remains inadequate. This study …

Abstract Human parvovirus B19 (HP-19) is the only Parvoviridae known to be pathogenic in
human. Studies of HP-19 infection and its associated life-threatening complications in sickle …